CV Therapeutics develops candidate SCD inhibitor for obesity, metabolic syndrome and diabetes March 26, 2009
Studies with SAR-150640 show potential importance of ADRB3 agonists in preventing preterm labor March 26, 2009
WAY-262611 acts as a Wnt beta-catenin agonist, increases bone formation in osteoporosis model March 25, 2009
RSS